Skip to main content

Advertisement

SpringerLink
Log in

Preeclampsia and subsequent breast cancer risk

  • Letter to the editor
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Prebil LA, Ereman RR, Powell MJ (2014) First pregnancy events and future breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants. Cancer Causes Control 25:859–868

    Article  PubMed Central  PubMed  Google Scholar 

  2. Levine RJ, Maynard SE, Qian C et al (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672–683

    Article  CAS  PubMed  Google Scholar 

  3. Xue F, Michels KB (2007) Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol. 8:1088–1100

    Article  PubMed  Google Scholar 

  4. Cheng D, Hao Y, Zhou W et al (2013) Vascular endothelial growth factor +936C/T, −634G/C, −2578C/A, and −1154G/A polymorphisms with risk of preeclampsia: a meta-analysis. PLoS ONE 8:e78173

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Troisi R, Braekke K, Harsem NK et al (2008) Blood pressure augmentation and maternal circulating concentrations of angiogenic factors at delivery in preeclamptic and uncomplicated pregnancies. Am J Obstet Gynecol 199:653.e1–653.e10

    Article  Google Scholar 

  6. Zhou Y, Genbacev O, Fisher SJ (2003) The human placenta remodels the uterus by using a combination of molecules that govern vasculogenesis or leukocyte extravasation. Ann N Y Acad Sci 995:73–83

    Article  CAS  PubMed  Google Scholar 

  7. Parr C, Watkins G, Boulton M et al (2005) Placenta growth factor is over-expressed and has prognostic value in human breast cancer. Eur J Cancer 41:2819–2827

    Article  CAS  PubMed  Google Scholar 

  8. Bear HD, Tang G, Rastogi P et al (2012) Bevacizumab added to neoadjuvant chemotherapy for breast cancer. N Engl J Med 366:310–320

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Assistance Publique Hopitaux de Paris, Paris 13 University, Bondy, France

    Lionel Carbillon & Claire Delahosseraye

Authors
  1. Lionel Carbillon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claire Delahosseraye
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lionel Carbillon.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carbillon, L., Delahosseraye, C. Preeclampsia and subsequent breast cancer risk. Cancer Causes Control 26, 955–956 (2015). https://doi.org/10.1007/s10552-015-0577-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-015-0577-5

Keywords

Search

Navigation